Aliskiren, a Direct Renin Inhibitor, in Clinical Practice: A New Approach in the Treatment of Hypertension

By  

Current Vascular Pharmacology, Vol. 8, Iss. 3, 2010-05 ,pp. : 344-362

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Direct Renin Inhibitor, Aliskiren, on Arterial Hypertension, Chronic Kidney Disease and Cardiovascular Disease: Optimal Pharmacotherapy

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 1, 2013-03 ,pp. : 77-82

Bentham Science Publishers

Access to resources Recommend Favorite

The Renin Inhibitor Aliskiren as Novel Treatment for Cardiovascular Disease

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 233-240

Bentham Science Publishers

Access to resources Recommend Favorite

Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension

By Mallion Jean-Michel   Omboni Stefano   Barton John   Van Mieghem Walter   Narkiewicz Krzysztof   Panzer Peter-Klaus   Puig Juan Garcíía   Stefanadis Christodoulos   Zweiker Robert    

Blood Pressure, Vol. 20, Iss. 1, 2011-04 ,pp. : 3-11

Informa Healthcare

Access to resources Recommend Favorite

Real‐world incidence of efficacy and safety outcomes in patients on direct oral anticoagulants with left ventricular systolic dysfunction at a tertiary referral center

By  

Clinical Cardiology, Vol. 40, Iss. 12, 2017-12 ,pp. : 1328-1332

John Wiley & Sons Inc

Access to resources Recommend Favorite